Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma

Published:2020-03 Issue:3 Volume:271 Page:534-541
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Wang Zheng,Peng Yuanfei,Hu Jingwu,Wang Xiaoying,Sun Huichuan,Sun Jian,Shi Yinghong,Xiao Yongsheng,Ding Zhenbing,Yang Xinrong,Tang Min,Tang Zhaoyou,Wang Jiping,Lau Wan Y.,Fan Jia,Zhou Jian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference51 articles.

1. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update;Omata;Hepatol Int,2017

2. Prognostic prediction and treatment strategy in hepatocellular carcinoma;Bruix;Hepatology,2002

3. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

4. Liver resection for cancer: new developments in prediction, prevention and management of postresectional liver failure;van Mierlo;J Hepatol,2016

5. ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a scandinavian multicenter randomized controlled trial (LIGRO trial);Sandstrom;Ann Surg,2018

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The combination of ALPPS, interventional hepatoma therapy, targeted therapy, and immunotherapy: A novel conversion therapy model for unresectable HCC;2024-09-08

2. Pathological complete response after conversion therapy in unresectable hepatocellular carcinoma: a retrospective study;BMC Gastroenterology;2024-07-30

3. Liver fibrosis as a predictor of liver failure and outcome following ALPPS among patients with primary liver cancer;Scientific Reports;2024-07-09

4. Should the one-stage hepatectomy be performed for hepatitis B virus-related hepatocellular carcinoma patients with liver fibrosis or cirrhosis when the RLV/SLV is between 30% to 40%?;2024-06-26

5. Recent advances in surgical management strategies for hepatocellular carcinoma;hLife;2024-06